AIMS/HYPOTHESIS: To determine whether genetic variation in uncoupling protein-1 (UCP-1) is associated with obesity or obesity-related risk factors in overweight women. METHODS: We genotyped 526 overweight/obese women (mean body mass index 34.1 kg/m2, range 25.0 to 47.5 kg/m2) for the -3826 A-->G uncoupling protein-1 polymorphism. Of the 526 women genotyped 144 had fasting blood samples analysed for glucose and lipid measurements. RESULTS: The -3826 G allele was found with a frequency of 0.23 and was associated with higher BMI (p = 0.02). A higher frequency of this polymorphism (0.33) was found in subjects with Type II (non-insulin-dependent) diabetes mellitus (p = 0.02), though adjustment for BMI weakened this significance (p = 0.06). The -3826 G variant was associated with increased fasting glucose (p = 0.01). This was, however, a result of a greater proportion of women with Type II diabetes also having the G variant (p = 0.10, adjusted for Type II diabetes). The -3826 G variant of uncoupling protein-1 did not have an effect on other metabolic variables associated with obesity. CONCLUSION/ INTERPRETATION: In overweight Australian women the -3826 G variant of UCP-1 increased the susceptibility to obesity indicating that UCP-1 could be involved in weight regulation.
AIMS/HYPOTHESIS: To determine whether genetic variation in uncoupling protein-1 (UCP-1) is associated with obesity or obesity-related risk factors in overweight women. METHODS: We genotyped 526 overweight/obesewomen (mean body mass index 34.1 kg/m2, range 25.0 to 47.5 kg/m2) for the -3826 A-->G uncoupling protein-1 polymorphism. Of the 526 women genotyped 144 had fasting blood samples analysed for glucose and lipid measurements. RESULTS:The -3826 G allele was found with a frequency of 0.23 and was associated with higher BMI (p = 0.02). A higher frequency of this polymorphism (0.33) was found in subjects with Type II (non-insulin-dependent) diabetes mellitus (p = 0.02), though adjustment for BMI weakened this significance (p = 0.06). The -3826 G variant was associated with increased fasting glucose (p = 0.01). This was, however, a result of a greater proportion of women with Type II diabetes also having the G variant (p = 0.10, adjusted for Type II diabetes). The -3826 G variant of uncoupling protein-1 did not have an effect on other metabolic variables associated with obesity. CONCLUSION/ INTERPRETATION: In overweight Australian womenthe -3826 G variant of UCP-1 increased the susceptibility to obesity indicating that UCP-1 could be involved in weight regulation.
Authors: Raymond E Soccio; Zhenghui Li; Eric R Chen; Yee Hoon Foong; Kiara K Benson; Joanna R Dispirito; Shannon E Mullican; Matthew J Emmett; Erika R Briggs; Lindsey C Peed; Richard K Dzeng; Carlos J Medina; Jennifer F Jolivert; Megan Kissig; Satyajit R Rajapurkar; Manashree Damle; Hee-Woong Lim; Kyoung-Jae Won; Patrick Seale; David J Steger; Mitchell A Lazar Journal: J Clin Invest Date: 2017-02-27 Impact factor: 14.808
Authors: G Labruna; F Pasanisi; C Nardelli; G Tarantino; D F Vitale; R Bracale; C Finelli; M P Genua; F Contaldo; L Sacchetti Journal: J Endocrinol Invest Date: 2009-03-26 Impact factor: 4.256
Authors: Adauto V Ramos; Luciana Bastos-Rodrigues; Bruna A Resende; Eitan Friedman; Luciana Campanha-Versiani; Debora M Miranda; Marta Sarquis; Luiz De Marco Journal: BMC Med Genet Date: 2012-11-07 Impact factor: 2.103
Authors: Bianca M de Souza; Letícia A Brondani; Ana P Bouças; Denise A Sortica; Caroline K Kramer; Luís H Canani; Cristiane B Leitão; Daisy Crispim Journal: PLoS One Date: 2013-01-24 Impact factor: 3.240
Authors: Michèle M Sale; Fang-Chi Hsu; Nicholette D Palmer; Candace J Gordon; Keith L Keene; Hermina M Borgerink; Arun J Sharma; Richard N Bergman; Kent D Taylor; Mohammed F Saad; Jill M Norris Journal: BMC Endocr Disord Date: 2007-03-30 Impact factor: 2.763
Authors: Letícia A Brondani; Tais S Assmann; Bianca M de Souza; Ana P Bouças; Luis H Canani; Daisy Crispim Journal: PLoS One Date: 2014-05-07 Impact factor: 3.240
Authors: Shahanas Chathoth; Mona H Ismail; Chittibabu Vatte; Cyril Cyrus; Zhara Al Ali; Khandaker Ahtesham Ahmed; Sadananda Acharya; Aisha Mohammed Al Barqi; Amein Al Ali Journal: BMC Med Genet Date: 2018-11-20 Impact factor: 2.103